PCN67 Estimating Cost-Effectiveness of Pembrolizumab in Advanced Esophageal Cancer Based on the Keynote-181 Trial
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.159
https://www.valueinhealthjournal.com/article/S1098-3015(21)00376-4/fulltext
Title :
PCN67 Estimating Cost-Effectiveness of Pembrolizumab in Advanced Esophageal Cancer Based on the Keynote-181 Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00376-4&doi=10.1016/j.jval.2021.04.159
First page :
Section Title :
Open access? :
No
Section Order :
10736